News
Latest news from CHV and our portfolio companies
Featured News
Acquisition adds next-generation CLAAS® AcuFORM™ Technology to Gore’s portfolio CAUTION: Investigational Device. Limited by federal (or United States) law to investigational use. Outside the United States, the device is intended exclusively for…
Insights & Impacts: The latest from CHV
After promising results from first-in-man studies with its novel Neural Ice™ technology, the Massachusetts-based company
AtaCor Medical Inc., a privately-held medical device company delivering the next generation of extravascular leads
Advancements help neurologists detect and analyze suspected seizure events from patients in home healthcare settings
Avive Solutions, Inc., the developer of the world’s most advanced connected automated external defibrillator (AED)
Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health
Brixton Biosciences, a clinical-stage life sciences company developing novel therapies for chronic and acute pain,
The round was led by SPRIG Equity with participation from all major Series C investors
Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health
PreTRM® test-and-treat strategy demonstrates statistically and clinically significant improvement in neonatal health outcomes and hospital
Data to be presented on February 3rd during a Spotlight Session at AF Symposium 2023